Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studies

MLA

Bhabita Mayer, et al. “Efficacy and Safety of Mepolizumab in Korean Patients with Severe Eosinophilic Asthma from the DREAM and MENSA Studies.” The Korean Journal of Internal Medicine, vol. 36, Mar. 2021, pp. 362–70. EBSCOhost, https://doi.org/10.3904/kjim.2019.198.

APA

Bhabita Mayer, Choon-Sik Park, Mi-Kyeong Kim, Nam-Hee Kwon, Hae-Sim Park, Soung-Jun Min, Frank C. Albers, & Steven W. Yancey. (2021). Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studies. The Korean Journal of Internal Medicine, 36, 362–370. https://doi.org/10.3904/kjim.2019.198

Chicago

Bhabita Mayer, Choon-Sik Park, Mi-Kyeong Kim, Nam-Hee Kwon, Hae-Sim Park, Soung-Jun Min, Frank C. Albers, and Steven W. Yancey. 2021. “Efficacy and Safety of Mepolizumab in Korean Patients with Severe Eosinophilic Asthma from the DREAM and MENSA Studies.” The Korean Journal of Internal Medicine 36 (March): 362–70. doi:10.3904/kjim.2019.198.